EP4211598
A SCORING METHOD FOR AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE THERAPY
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
11.9.2021EP published:
7.1.2026EP application number:
21772839.3
EPO information:
European Patent Register
Max expiry date:
10.9.2041Expiry date:
10.9.2026
Title in English:
A SCORING METHOD FOR AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE THERAPYLanguage of the patent:
English
Timeline
Today
11.9.2021EP application
7.1.2026EP Publication
10.9.2026Expires
Owner
Name:
AstraZeneca UK LimitedAddress:
1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge CB2 0AA, GB
Name:
Daiichi Sankyo Company, LimitedAddress:
3-5-1 Nihonbashi-honcho Chuo-ku, Tokyo 103-8426, JP
Inventor
Name:
SCHMIDT, GuenterAddress:
80999 Munich, DE
Name:
BRIEU, NicolasAddress:
81543 Munich, DE
Name:
SPITZMUELLER, AndreasAddress:
83052 Bruckmuehl, DE
Name:
KAPIL, AnshAddress:
80339 Munich, DE
Priority
Number:
202063077604 PDate:
12.9.2020Country:
US
Classification
Categories:
G06F 18/2413